Weekly Rundown: Lilly, NVIDIA to build pharma's most powerful AI supercomputer Another biotech retreats from AAV, a promising antibiotic, a paused CRISPR trial, and more led the news this week.

https://www.drugdiscoverynews.com/weekly-rundown-lilly-nvidia-to-build-pharma-s-most-powerful-ai-supercomputer-16770